Can a subclinical varicocele cause testicular atrophy in an adolescent or adult male?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can a Subclinical Varicocele Cause Testicular Atrophy?

Yes, subclinical varicoceles can cause testicular atrophy, but they should not be treated because treatment does not improve fertility outcomes. 1

Key Evidence from Guidelines

The 2025 European Association of Urology guidelines provide a strong recommendation stating: "Do not treat varicocele in infertile men who have normal semen analysis or in men with a subclinical varicocele." 1 This recommendation is based on evidence showing that treatment of subclinical varicoceles was not effective at increasing the chances of spontaneous pregnancy. 1

Understanding the Paradox

While subclinical varicoceles can be associated with decreased testicular volume, this does not translate into a clinically meaningful impact on fertility:

  • Research confirms the association: A 1997 study demonstrated that men with subclinical left varicoceles had significantly reduced left testicular volume compared to right testicular volume (13.2 versus 14.7 mL). 2 This finding parallels what occurs with clinical varicoceles.

  • But atrophy doesn't predict infertility: A 1994 study of 946 men found that while varicoceles cause significant ipsilateral testicular atrophy/hypotrophy, there was no correlation between loss of testicular volume and fertility status in men with left varicoceles. 3 Both fertile and infertile men with varicoceles showed similar degrees of testicular volume loss.

  • Treatment doesn't help: The critical point is that treating subclinical varicoceles does not improve pregnancy rates, even when testicular volume differences exist. 1, 4

Clinical Algorithm for Management

For adults with subclinical varicocele:

  • Observation only, regardless of testicular size discrepancy
  • No surgical intervention indicated
  • Focus on other potential causes of infertility if present

For adolescents with subclinical varicocele:

  • The guidelines do not recommend treatment
  • Even in adolescents, surgery is only indicated for clinical varicoceles with persistent testicular size difference >2 mL or 20%, confirmed on two visits 6 months apart 1

Important Caveats

Do not confuse subclinical with clinical varicoceles: The distinction is crucial. Clinical varicoceles (palpable on examination) with abnormal semen parameters in infertile men should be treated, as this improves fertility rates. 1 Subclinical varicoceles (detected only by imaging, not palpable) should not be treated.

Avoid the trap of treating based on ultrasound findings alone: Routine ultrasonography to investigate presumed varicocele should be discouraged, as treatment of non-palpable varicoceles is not associated with improvement in either semen parameters or fertility rates. 5

The evidence is clear and consistent: while subclinical varicoceles may be associated with some degree of testicular volume loss, this finding alone does not warrant intervention because treatment does not improve the outcomes that matter—fertility, pregnancy rates, and quality of life.

Related Questions

Can a 3.4mm subclinical varicocele (varicose vein in the scrotum) that cannot be palpated cause testicular atrophy?
I have a 3.5 mm non‑palpable, painful varicocele causing testicular atrophy; should I undergo percutaneous embolisation?
What is the treatment for a 16-year-old with varicocele?
Can a non-palpable varicocele (varicose vein in the scrotum) of 3.4mm diameter cause testicular atrophy in a patient with this condition?
Do I need to worry about an atrophied testicle due to varicocele (varicose vein in the testicle)?
What are the indications for finerenone in adult patients with chronic kidney disease and type 2 diabetes mellitus who are receiving an ACE inhibitor or angiotensin‑receptor blocker?
What ultrasound findings favor a diagnosis of uterine leiomyoma?
What is the appropriate pharmacologic agent for smoking cessation in a 56-year-old patient with a 20 pack-year smoking history?
What is the recommended time window for administering tissue plasminogen activator (tPA, alteplase) in a patient with suspected high‑risk (massive) pulmonary embolism?
What is the appropriate management for a 38‑week‑gestation female neonate whose Foley catheter has become dislodged?
For a 50‑year‑old woman with a 1 cm stage I invasive ductal carcinoma (Oncotype 7) treated with radiation 6 months ago, a long history of indoor tanning, two recent tanning sessions, weight gain, and severe depression, what is her melanoma risk and what preventive and surveillance measures should be recommended?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.